Statistics

Total Visits

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group64

Select a period of time:

Number of views in the range

Views
Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group41

Views

Views
March 202515
April 20252
May 20251
June 20251
July 202522
August 20250
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States9
Brazil6
Uruguay2
Canada1
Chile1
Egypt1
Spain1
United Kingdom1
Jamaica1
 

Top cities views

Views
Montevideo2
Ananindeua1
Bertioga1
Caracas1
Chicago1
Council Bluffs1
Dallas1
Fort Worth1
Harrow1
Iconha1